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Reference values for quantitative left
ventricular and left atrial measurements
in cardiac computed tomography
Abstract To assess reference values
for left ventricular (LV) and left atrial
(LA) dimensions, global LV function,
and LV-myocardial mass for cardiac
CT. We examined 120 subjects un-
dergoing a coronary angiography
using 64-slice and dual-source CT. All
individuals had a low cardiovascular
risk, normal ECG, negative biomar-
kers, and a normal cardiac CT exam-
ination. All subjects had a negative
medical history of cardiovascular dis-
ease both on admission and at clinical
6-month follow-up. The following
measurements were obtained: septal
wall thickness (SWT), posterior wall
thickness (PWT), LV inner diameter
(LVID), LA anterior posterior diame-
ter (LADsys), end-systolic volume
(ESV), and end-diastolic volume
(EDV), LV-myocardial mass
(LVMM). We found significant gen-
der-related differences for all LV
dimensions (SWTsys, SWTdia,PWTsys,
PWTdia,LVIDsys,LVIDdia). LADsys
showed no significant difference be-
tween males and females. Significant
differences were found for global LV
functional parameters including ESV,
EDV, and SV, whereas no significant
differences were found for the EF. LV-
myocardial mass parameters showed
significant gender-related differences.
No significant correlation was found
between any of these parameters and
age. All data were transferred to
percentile ranks. This study provides
gender-related reference values and
percentiles for LVand LA quantitative
measurements for cardiac CT and
should assist in interpreting results.
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Introduction
The assessment of cardiac chamber dimensions, ventricular
function, and myocardial mass represents an important
component for the diagnosis of cardiac disease, for risk
stratification, and therapeutic decision making, and is of
high prognostic value in patients with ischemic and non-
ischemic cardiomyopathy [1, 2].
Recent advances in multi-detector row computed tomo-
graphy (CT) technology have continuously increased the
role of the non-invasive technique for imaging of coronary
arteries [3–7]. Actually, patients with stable angina pectoris
and inconclusive electrocardiogram (ECG) or stress test are
recommended to have a CT coronary angiography [8, 9].
Since coronary artery imaging with CT is performed with
ECG gating, images in multiple phases throughout the
cardiac cycle are obtained that allow depiction of the left
ventricle (LV) in diastole and systole and quantification of
global LV function with similar accuracy when compared
to magnetic resonance imaging (MRI) [10–13]. Similarly,
detailed anatomic data about the size and shape of the left
atrium (LA) are obtained that correlate well with results
from echocardiography [14].
Normal ranges of LV and LA dimensions, global LV
function, and myocardial mass have been established in
healthy individuals for echocardiography [15–17] and for
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MRI using steady-state free precession [18, 19] and
gradient echo sequences [18, 20, 21]. However, CT studies
on LV and LA dimensions are still lacking, and reference
values of LV and LA dimensions, global LV function, and
myocardial mass parameters have not yet been defined for
cardiac CT. This appears particularly intriguing, because
cardiac CT is increasingly used, and it provides data about
chamber dimensions and functions as a spin-off from each
CT coronary angiography examination, without increasing
the amount of radiation or administered contrast media to
the patient. In addition, since slight but systematic
differences between CT and MRI measurements of global
LV volumes and function have been repetitively shown
[22], the need for modality-specific reference values is
further enhanced. The purpose of this study was to
establish gender-specific reference values for LV and LA
dimensions, global LV function, and LV myocardial mass
for cardiac CT.
Materials and methods
One hundred and twenty individuals including 67 female
patients (mean age 57.0±9.5 years, range 40–70 years) and
53 male patients (mean age 54.1±8.3 years, range 40–
70 years) who had undergone a clinically indicated cardiac
CT coronary angiography between January 2005 and
October 2006 were retrospectively included in this study.
Reasons for referral were atypical chest pain with negative
ECG negative and biomarkers on admission in all
individuals. The medical history was available in all
subjects and included information about cardiovascular
risk factors such as a positive family history, hyperlipide-
mia, diabetes mellitus, nicotine abuse, and arterial
hypertension.
We selected normotensive (blood pressure <140/90 mmHg)
individuals with sinus rhythm who had a low pre-test
probability of coronary artery disease (based on the
Framingham criteria [23]). All individuals had no
abnormalities in previous echocardiographies (which
was available in 19 subjects), and all had no history of
cardiac disease (i.e., myocardial infarction, cardiac sur-
gery, or intervention). Patients were included when their
Agatston score was below the 25th age- and gender-
matched percentile [24], and in whom coronary artery
stenoses (in this study defined as any vessel diameter
reduction) could be reliably excluded with CT coronary
angiography. Conventional catheter angiography was not
considered clinically indicated in any subject of the
population.
Exclusion criteria were ECG abnormalities, any medi-
cation, history of arterial hypertension, and obesity [body
mass index (BMI) >30 kg/cm2]. CT exclusion criteria were
allergy to iodine-containing contrast medium and nephrop-
athy (serum creatinine level >150 μmol/l).
Patients were followed-up by chart reviews for 6 months.
Patients requiring repeat cardiovascular testing over this
period, suffering from death from any cause, from cardiac
death, non-fatal myocardial infarction, unstable angina,
recurrent chest pain, or coronary revascularization were
excluded. On subsequent clinical follow-up sessions, chest
pain was referred to as musculoskeletal in nature (n=88) or
as caused by gastrointestinal disorders (n=32).
Cardiac multi-detector row CT
Cardiac CT examinations were obtained on a 64-slice CT
system (Somatom Sensation 64; Siemens Medical Solu-
tions, Forchheim, Germany) in 33 individuals using the
following scanning parameters: tube current-time product
650 mAs, tube voltage 120 kV, slice collimation 32×
0.6 mm, slice acquisition 64×0.6 mm by means of a z-
flying focal spot, gantry rotation time 330 ms, pitch 0.2,
reconstructed slice thickness 1 mm (increment 0.75 mm),
using a soft tissue convolution kernel (B30f). A dual-
source CT system (Somatom Definition, Siemens Medical
Solutions, Forchheim, Germany) was used in 87 indivi-
duals using the following CT parameters: tube current-time
product 350 mAs/rotation, tube voltage 120 kV, slice
collimation 2×32×0.6 mm, slice acquisition 64×0.6 mm
by means of a z-flying focal spot, gantry rotation time
330 ms, pitch 0.20–0.53 (depending on the heart rate),
reconstructed slice thickness 0.75 mm (increment 0.5 mm),
using a soft tissue convolution kernel (B26f).
All images were acquired during mid-inspiration with
the subjects in a supine position and elevated arms. No
beta-blockers for heart rate control were given prior to CT
in any patient.
With 64-slice CT, 80 ml of iodixanol (Visipaque 320,
320 mg/ml, GE Healthcare, Buckinghamshire, UK)
followed by 30 ml saline solution was injected into an
antecubital vein via a 18-gauge catheter (injection rate
5 ml/s). With dual-source CT, a two-phasic contrast media
protocol (first phase: 60–80 ml contrast, second phase:
same amount as first phase with 20% contrast medium and
80% saline solution) was used that was adjusted to the
varying scan duration. Bolus tracking was used with both
CT systems for initiating the main data acquisition as soon
as the attenuation in the ascending aorta reached the
threshold of 120 Hounsfield units. Data acquisition was
performed in a cranio-caudal direction from the tracheal
bifurcation to the diaphragm. ECG-gated tube pulsing for
radiation dose reduction was used in all examinations.
ECG-gated pulsing was switched on at 60% of the R-R
interval when 64-slice CTwas employed. With dual-source
CT, the ECG-pulsing window was adapted according to the
heart rate, as previously recommended [25].
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CT image reconstruction
In the 64-slice CT system the adaptive cardiac volume
approach was used for image reconstruction. This approach
automatically switches between one- and two-segment
reconstructions depending on the patient’s heart rate.
Scanning with dual-source CT was performed in a mono-
segment reconstruction mode [26]. Retrospective ECG-
gating was used to synchronize data reconstruction with the
ECG, and images were reconstructed in increments of 5%
steps from 0% to 95% of the RR interval. All data were
post-processed on a second Wizard (Siemens Medical
Solutions) equipped with cardiac post-processing software
(Syngo Circulation, Siemens Medical Solutions). The
estimated radiation doses using these CT protocols were
approximately 11 mSv for 64-slice CT [27] and 7–9 mSv
for dual-source CT [28].
CT data analysis
End-systolic and end-diastolic phases were visually
identified by one experienced reader on multi-planar
reformations (MPR). End-systole was visually defined as
the phase with smallest LV volume; end-diastole was
defined as the phase with largest LV volume. Measure-
ments in end-systole and end-diastole of the specific
parameters were taken at the same orientation and level.
The following measurements were obtained:
(1) LV dimensions
All measurements of LV dimensions were obtained at
the chorda level and were performed according to the
international recommendations for chamber quantification
in echocardiography [17].
a. Septal wall thickness in end-systole (SWTsys) and end-
diastole (SWTdia) was measured on short-axis MPR in
the orientation of the four-chamber plane (Fig. 1).
b. Posterior wall thickness in end-systole (PWTsys) and
end-diastole (PWTdia) was measured on short-axis MPR
in the orientation of the four-chamber plane (Fig. 1).
c. LV inner diameter in end-systole (LVIDsys) and end-
diastole (LVIDdia) was measured in the four-chamber
MPR (Fig. 1).
d. Relative wall thickness (RWT) was calculated using
the formula: RWT = 2xPWTdia/LVIDdia
(2) LA dimension
a. LA anterior posterior diameter in end-systole (LADsys)
was measured on axial oblique MPR through the level
of the aortic valve and parallel to the LV outflow tract
in a strictly anterior-posterior orientation (Fig. 2).
Confluences of pulmonary veins were excluded, as
previously recommended [17].
(3) Global LV function
LV epicardial and endocardial contours were semi-
automatically detected by the software; the contour
detection was visually checked and manually corrected if
considered necessary (Fig. 3). Papillary muscles were
included in the LV cavity. The following global LV
functional parameters were calculated:
a. End-systolic volume (ESV)
b. End-diastolic volume (EDV)
c. Stroke volume (SV) by using the formula SV= EDV-EDV
d. Ejection fraction (EF) by using the formula EF[%] =
SVx100/EDV
Fig. 1 Multi-planar reformations of a cardiac CT examination at
end-diastole. Short-axis reformation (yellow box) was defined
perpendicular to the long-axis. Septal wall thickness (SWT, black
arrows) and posterior wall thickness (PWT, white arrowheads)
measurements were obtained at the chorda level. Four-chamber
reformation (green box) shows left ventricle and left atrium as well
as right ventricle and right atrium at the mid-ventricular level. Black
arrow indicates left ventricular inner diameter (LVID). Two chamber
reformation (blue box) demonstrates the long axis (green line)
defined from the mid-level of the mitral valve to the apex of the left
ventricle
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4) LV myocardial mass parameters
a. LV myocardial mass (LVMM) by using the formula
LVMM = (epicardial myocardial volume–endocardial
myocardial volume) × 1.04 g/ml (Fig. 3).
b. LV myocardial mass index (LVMMI) was calculated
by the formula LVMMI = LVMM/BSA (BSA being
the body surface [29]).
To test for inter-observer variability of left heart
measurements, data from 25 subjects (7 from the 64-slice
CT group, 18 from the dual-source CT group, representing
the distribution to the two scanners) were independently
analyzed by a second reader using the same criteria
mentioned above. To test for intra-reader variability, the
first reader re-analyzed the same 25 studies after 6 weeks.
Both the intra-reader variability and the inter-reader
variability were low (Table 1); therefore, the remaining
95 individuals were evaluated by only one reader.
Statistical analysis
All quantitative variables are described as mean ± standard
deviation. The data were descriptively reviewed and
statistically analyzed using Kolmogorov-Smirnov’s to test
for normality. Student’s t-test for independent samples was
used to test for CT system- and gender-specific differences.
Univariate analysis of variances with post hoc Bonferroni
correction was used to compare groups of different age
decades. Correlation between dual-source CT measure-
ments and age was tested through Pearson’s linear
regression. Inter- and intra-reader variability was tested
using the concordance correlation coefficient. Percentiles
were calculated from the standard normal table, repre-
senting the probability of a score occurring. P values
<0.05 were considered statistically significant. Data
analysis was performed using commercially available
software (SPSS 12.0, Chicago, IL; MedCalc 9.0.2,
Mariakerke, Belgium).
Fig. 2 Multi-planar reformations of a cardiac CT examination at
end-systole. Axial oblique reformation (yellow box) was defined to
show the long-axis and to run through the mid-level of the aortic
valve, parallel to the LV outflow tract (blue line). The left atrium in
the anterior-posterior orientation is visualized (green box). Left atrial
diameter (LAD) was measured in the same orientation (black arrow)
Fig. 3 Multi-planar reforma-
tions of a cardiac CT examina-
tion indicating epicardial (green
lines) and endocardial (red lines)
contours of the left ventricle in
end-systole in the short-axis
(left) and long-axis (right). Epi-
cardial and endocardial volumes
were calculated for global left
ventricular function and left
ventricular myocardial mass
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Results
All measurements could be obtained in each patient. Mean
heart rate was 59.3±4.6 bpm (range 47–64 bpm) in patients
undergoing 64-slice CT, and was 72.7±17.4 (range 44–
89 bpm) in the patients undergoing dual-source CT. The
mean BMI in men was 23.7 kg/cm2±2.8 (range 18.5–
29.8 kg/cm2) with a mean BSA of 1.94±0.19 m2 (range
1.53–2.38 m2). Mean BMI in women was 22.8 kg/cm2±2.7
(range 17.6–27.7 kg/cm2) with a mean BSA of 1.78±
0.19 m2 (range 1.41–2.03 m2).
All quantitative variables except the heart rate showed a
normal distribution. No significant gender-specific differ-
ences were found for the age, heart rate, and BMI.
Significant gender-specific differences were found for the
BSA (P<0.05).
Comparisons of all dimensional (SWTsys, P=0.23;
SWTdia, P=0.37; PWTsys, P=0.47; PWTdia, P=0.81;
LVIDsys, P=0.72; LVIDdia, P=0.96; LADsys, P=0.57),
functional (ESV, P=0.24; EDV, P=0.52; EF, P=0.20), and
LV mass parameters (LVMM, P=0.35; LVMMI, P=0.14)
between 64-slice CT and dual-source CT showed no
significant differences. Thus, data from both CT systems
were pooled for subsequent analysis. Similarly, no signif-
icant differences between patients undergoing 64-slice CT
or dual-source CT were found for BMI and BSA.
Table 2 displays parameters and P values for gender-
specific comparisons. Significant differences between men
and women were found for all parameters of LV
dimensions, including SWTsys, SWTdia, PWTsys, PWTdia,
LVIDsys, LVIDdia, and RWT. LADsys showed no significant
differences between males and females. Significant differ-
Table 1 Concordance correla-
tion coefficients for inter- and
intra-reader variability (n=25)
LV: left ventricle, LA: left atri-
um, sys: end-systole, dia:
end-diastole
Parameters Inter-reader Intra-reader
LV dimensions Septal wall thickness, SWTsys 0.79 0.82
Septal wall thickness, SWTdia 0.84 0.80
Posterior wall thickness, PWTsys 0.86 0.89
Posterior wall thickness, PWTdia 0.86 0.84
LV inner diameter, LVIDsys 0.81 0.79
LV inner diameter, LVIDdia 0.86 0.83
LA dimension LA anterior-posterior diameter, LADsys 0.91 0.86
Global LV function End-systolic volume, ESV 0.95 0.88
End-diastolic volume, EDV 0.93 0.89
LV myocardial mass parameters LV myocardial mass, LVMM 0.97 0.98
Table 2 Descriptive characteristics (mean and SD) of LV and LA dimensions, global LV function, and LV myocardial mass in males and
females with P values for gender-specific comparisons
Parameters Males (n=53) Females (n=67) P values
Mean SD Mean SD
LV dimensions Septal wall thickness, SWTsys [cm] 1.3 0.2 1.1 0.2 <0.05
Septal wall thickness, SWTdia [cm] 0.9 0.2 0.8 0.1 <0.05
Posterior wall thickness, PWTsys [cm] 1.5 0.3 1.4 0.2 <0.05
Posterior wall thickness, PWTdia [cm] 0.9 0.2 0.8 0.2 <0.05
LV inner diameter, LVIDsys [cm] 2.9 0.5 2.8 0.4 <0.05
LV inner diameter, LVIDdia [cm] 4.5 0.5 4.4 0.5 <0.05
Relative wall thickness (RWT) 0.42 0.11 0.38 0.08 <0.05
LA dimension LA anterior posterior diameter, LADsys [cm] 3.5 0.5 3.4 0.5 0.46
Global LV function End-systolic volume, ESV [ml] 47 19 40 12 <0.05
End-diastolic volume EDV [ml] 144 38 115 7 <0.05
Stroke volume, SV [ml] 95 29 76 18 <0.05
Ejection fraction, EF [%] 66 9 66 7 0.89
LV myocardial mass parameters LV myocardial mass, LVMM [g] 167 38 129 29 <0.05
LV mass index, LVMMI [g/m2] 86 18 68 13 <0.05
LA: left atrium, LV: left ventricle, dia: end-diastole, sys: end-systole, SD: standard deviation
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ences were found for global LV functional parameters,
including ESV, EDV, and SV, whereas no significant
differences were found for the EF. LV myocardial mass
parameters (i.e., LVMM and LVMMI) showed significant
differences between male and female patients.
Percentiles of LV and LA dimensions, global LV
functional parameters, and LV myocardial mass parameters
are shown for males in Table 3 and for females in Table 4.
Individuals were grouped according to age decades, with
group I ranging from 40–49 years (n=30), group II ranging
from 50–59 years (n=45), and group III ranging from 60–
70 years (n=45). A significant difference was found for
SWTsys between subgroups II and III in women (P<0.05).
No other significant differences between all subgroups and
for all other parameters were found.
LV and LA dimensions did not significantly correlate
with age, testing males and females separately. Global LV
functional parameters showed no significant correlation
with age; only the SV showed a trend towards reduction
with increasing age in women (r=−0.22,P=0.07). No
significant correlation was found between age and both LV
myocardial mass parameters.
Discussion
Cardiac CT is an emerging investigation that has already
entered daily clinical routine in many institutions. With each
cardiac CT, auxiliary data about left heart size, volumes, and
myocardial mass are obtained that should be provided to the
referring physician in addition to the information about the
presence or absence of coronary artery disease.
Ethical concerns about radiation dose and potentially
nephrotoxic contrast medium administration are the two
most likely dilemmas why CT reference values of left heart
measurements in healthy individuals have not yet been
assessed. These two inherent shortcomings of CT will not
be resolved in the near future. In this study, we tried to
approach a normal, healthy population by including only
normotensive subjects with sinus rhythm having a low risk
of cardiovascular disease, no obesity, no history of cardiac
disease, no electrocardiography or biomarker evidence of
cardiac disease, no medication, and no evidence of cardiac
disease at the 6-month follow-up. In addition, coronary
artery disease was reliably excluded with CT coronary
angiography in all subjects of this study. By doing so, our
study is the first–to the best of our knowledge–that
provides normal cardiac CT reference values of left heart
measurements allowing the definition of the limit between
normal and disease states. Transmitting the principles of
echocardiography [17] to CT, the reference values provided
in this study for RWT combined with LVMMI permit the
identification of LV remodeling and characterization of
concentric or eccentric hypertrophy (Fig. 4).
All data from this study showed a normal distribution
and could be therefore transformed to gender-related
percentiles. These are clinically easy to handle and allow
for the assignment of quantitative left heart measurements.
The percentile rank stratifies absolute quantitative left heart
measures and allows flexible thresholds to be set that
account for the independent effect of gender [24]. In
general, reference values are bound by two limits and
contain 95% of the values found in healthy individuals. In
order to define an increase or decrease of any parameter,
the 2.5th and the 97.5th percentile value should be taken as
threshold. Gender-specific values have to be taken into
account, because differences exist in LV morphology and
function between men and women [20].
Table 3 Percentiles for LV and LA dimensions, global LV function, and LV myocardial mass parameters in males
Parameters 2.5th 10th 25th 50th 75th 90th 97.5th
LV dimensions Septal wall thickness, SWTsys [cm] 0.8 1.0 1.1 1.3 1.5 1.6 1.7
Septal wall thickness, SWTdia [cm] 0.6 0.7 0.8 0.9 1.0 1.1 1.2
Posterior wall thickness, PWTsys [cm] 1.0 1.2 1.4 1.5 1.7 1.9 2.1
Posterior wall thickness, PWTdia [cm] 0.6 0.7 0.8 0.9 1.0 1.2 1.3
LV inner diameter, LVIDsys [cm] 2.1 2.4 2.7 3.0 3.3 3.6 3.9
LV inner diameter, LVIDdia [cm] 3.6 3.9 4.2 4.5 4.8 5.2 5.5
Relative wall thickness (RWT) 0.20 0.28 0.35 0.42 0.49 0.56 0.64
LA dimension LA anterior posterior diameter, LADsys [cm] 2.6 2.9 3.2 3.5 3.8 4.2 4.5
Global LV function End-systolic volume, ESV [ml] 9 22 34 47 60 72 85
End-diastolic volume EDV [ml] 70 95 119 144 170 193 219
Stroke volume, SV [ml] 37 57 75 95 114 132 152
Ejection fraction, EF [%] 48 54 59 66 72 77 83
LV myocardial mass parameters LV myocardial mass, LVMM [g] 92 118 141 167 192 215 241
LV mass index, LVMMI [g/m2] 51 63 74 86 98 109 121
LV: left ventricle, LA: left atrium, sys: end-systole, dia: end-diastole
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LV and LA dimensions
LV and LA dimensional measurements are important
determinants for diagnosis, therapeutic decision making,
and prognosis. The LV size predicts adverse cardiovascular
events, including death, recurrent infarction, ventricular
arrhythmias, and mitral regurgitation [30]. Concentric
remodeling that is distinct from LV hypertrophy indepen-
dently predicts adverse cardiovascular events in patients
with a preserved EF [31]. LA size is a marker of the
severity and chronicity of diastolic dysfunction [32], and
enlargement of the LA diameter represents an independent
predictor of clinical cardiovascular events in middle-aged
and elderly adults [33].
We found significant differences for all LV dimensions
between men and women. Similar gender-specific differ-
ences were found regarding LV dimensions using MRI [20]
and echocardiography [17]. Our CT data regarding
SWTdia, PWTdia, LVIDdia, LADsys, and RWT are compar-
able to the reference values reported for echocardiography
[17]. The PWTsys and PWTdia values from our study are
similar to those reported for MRI [21].
Global LV function
Global LV functional parameters provide important
information to diagnose heart failure [1, 2, 34] and allow
to identify patients who are at risk of developing congestive
heart failure or death after valve replacement [35]. In the
evaluation of dilated cardiomyopathy, analysis of global
LV function shows diminution in systolic function with
increased ESV and EDV, resulting in a decreased EF [36].
LV volumes and EF provide valuable diagnostic informa-
tion and are of long-term prognostic importance for
patients [11, 12, 37].
Global LV function as assessed with CTwas shown to be
highly accurate [38] and provides a high correlation with
measurements from MRI [11–13]. It is important to note,
however, that small differences between CT and MRI
regarding measurements of EDV and ESV [11, 12] have
been repetitively reported. This reinforces the need for
modality-specific reference values. The assessment of global
LV function with 64-slice CT has recently shown an
excellent correlation with single photon emission CT [20].
We found significant differences for global LV func-
tional parameters, including ESV, EDV, and SV between
males and females, whereas no significant differences were
Fig. 4 Relative wall thickness (RWT) and left ventricular myocardial
mass index (LVMMI) allowing the categorization of left ventricular
hypertrophy as either concentric or eccentric. Concentric remodeling
is defined as normal left ventricular mass with increased RWT
Table 4 Percentiles for LV and LA dimensions, global LV function, and LV myocardial mass parameters in females
Parameters 2.5th 10th 25th 50th 75th 90th 97.5th
LV dimensions Septal wall thickness, SWTsys [cm] 0.7 0.9 1.0 1.1 1.2 1.3 1.4
Septal wall thickness, SWTdia [cm] 0.5 0.6 0.7 0.8 0.9 1.0 1.1
Posterior wall thickness, PWTsys [cm] 0.9 1.1 1.2 1.4 1.5 1.7 1.8
Posterior wall thickness, PWTdia [cm] 0.5 0.6 0.7 0.8 0.9 1.0 1.1
LV inner diameter, LVIDsys [cm] 2.0 2.3 2.5 2.8 3.1 3.3 3.6
LV inner diameter, LVIDdia [cm] 3.4 3.8 4.0 4.4 4.7 5.0 5.3
Relative wall thickness (RWT) 0.22 0.28 0.33 0.38 0.43 0.48 0.54
LA dimension LA anterior posterior diameter, LADsys [cm] 2.6 2.9 3.2 3.5 3.8 4.1 4.4
Global LV function End-systolic volume, ESV [ml] 17 25 32 40 48 55 63
End-diastolic volume EDV [ml] 102 106 111 115 120 124 129
Stroke volume, SV [ml] 40 52 64 76 88 99 112
Ejection fraction, EF [%] 52 57 61 66 71 75 80
LV myocardial mass parameters LV myocardial mass, LVMM [g] 73 92 109 129 148 165 184
LV mass index, LVMMI [g/m2] 42 51 59 68 77 85 94
LV: left ventricle, LA: left atrium, sys: end-systole, dia: end-diastole
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found for the EF. In addition, a tendency towards a
decrease in SV with an increase in the age of women could
be demonstrated. These gender- and age-dependent find-
ings are similar to those reported in MRI [18]. ESV, EDV,
and SV values in this study were similar to those reported
for MRI [17], whereas our ESVand EDV values are higher
than those reported in echocardiography [12]. However,
the three-dimensional capabilities of CT and MRI have
been shown to surpass the accuracy of two-dimensional
modalities, such as echocardiography [39].
Myocardial mass
Myocardial mass parameters provide important informa-
tion regarding diagnosis, risk stratification, and prognosis,
and the LVMM significantly correlates with cardiovascular
morbidity and mortality, while regression of LV myocar-
dial mass reduces the risk of cardiovascular events [40].
A recent study showed an excellent agreement regarding
LVMM values between 16-slice CT and MRI [21]. Our CT
reference values for LVMM and LVMMI are similar to
those reported for MRI [17] and in echocardiography [18,
21], and show significant differences between men and
women. These gender-specific differences have been
similarly reported for MRI [41] and echocardiography [21].
No significant correlations between LVMM, LVMMI,
and age in MRI in a population from 22 to 74 years of age
have been reported [42]. Our CT data also showed no
significant correlation in a population with a higher age
range. This is supported by the Framingham study showing
LVMM to remain relatively stable in healthy men and
women with advancing age [11, 12, 37].
Study limitations
The following study limitations need to be addressed. First,
most of our subjects did not have prior echocardiography
or MRI to verify normal cardiac dimensions and function.
Hence, there still remains an uncertainty of cardiac health.
To minimize this potential bias, we used strict inclusion
and exclusion criteria. Second, we used two different CT
scanner generations. However, several studies have shown
an excellent correlation regarding global LV function even
when using 16-slice CTand MRI [11, 12]. The CT scanners
used in this study are characterized by a higher temporal
and spatial resolution, most probably yielding even more
accurate results. Third, no evaluation of the right ventricle
and right atrium were performed. This would require
relatively homogenous contrast attenuation in the right
heart that is challenging with CT. Fourth, the papillary
muscles were included into volume measurements as part
of the LV cavity. On the other hand, the impact of inclusion
or exclusion of papillary muscles on global LV function
assessment has been shown to be negligible [43]. Fifth,
dimensional measurements were obtained at the chorda
level. As tendinous chords are small and linear structures,
measurements could differ considerably when changing
the orientation or position of the imaging plane only a few
millimeters towards the cardiac apex or base. On the other
hand, the same is true also for echocardiography and MRI.
Finally, the high inter- and intra-class correlation coeffi-
cients in our study indicate a relatively high degree of
reliability for such measurements.
Conclusion
Important clinical management decisions rely on quantitative
values characterizing dimensions, global function, and myo-
cardial mass of the left heart. This study provides gender-
related reference values and percentiles for LV and LA
quantitative measurements for cardiac CT, the modality that is
increasingly used for non-invasive imaging of the heart.
Knowledge of normal distribution of left heart measurements
and differences that exist between genders should assist in
correct interpretation of disease states with cardiac CT.
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